EP2265168A1 - Capsule endoscopique - Google Patents

Capsule endoscopique

Info

Publication number
EP2265168A1
EP2265168A1 EP09732765A EP09732765A EP2265168A1 EP 2265168 A1 EP2265168 A1 EP 2265168A1 EP 09732765 A EP09732765 A EP 09732765A EP 09732765 A EP09732765 A EP 09732765A EP 2265168 A1 EP2265168 A1 EP 2265168A1
Authority
EP
European Patent Office
Prior art keywords
endocapsule
hollow organ
sensor
bacterium
starting substance
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP09732765A
Other languages
German (de)
English (en)
Inventor
Sebastian Schmidt
Clemens Bulitta
Stefan FÖRTSCH
Norbert GLÄSEL
Rainer Graumann
Arne Hengerer
Ludwig Herbst
Rainer Kuth
Bernhard Roas
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Siemens AG
Original Assignee
Siemens AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Siemens AG filed Critical Siemens AG
Publication of EP2265168A1 publication Critical patent/EP2265168A1/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/07—Endoradiosondes
    • A61B5/073—Intestinal transmitters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B1/00—Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor
    • A61B1/00002—Operational features of endoscopes
    • A61B1/00011—Operational features of endoscopes characterised by signal transmission
    • A61B1/00016—Operational features of endoscopes characterised by signal transmission using wireless means
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B1/00—Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor
    • A61B1/00147—Holding or positioning arrangements
    • A61B1/00158—Holding or positioning arrangements using magnetic field
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B1/00—Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor
    • A61B1/04—Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor combined with photographic or television appliances
    • A61B1/041—Capsule endoscopes for imaging
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/14539—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring pH
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/14542—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring blood gases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/14546—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring analytes not otherwise provided for, e.g. ions, cytochromes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/68—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
    • A61B5/6846—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive
    • A61B5/6847—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive mounted on an invasive device
    • A61B5/6861—Capsules, e.g. for swallowing or implanting
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B1/00—Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor
    • A61B1/04—Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor combined with photographic or television appliances
    • A61B1/05—Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor combined with photographic or television appliances characterised by the image sensor, e.g. camera, being in the distal end portion
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/1455—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using optical sensors, e.g. spectral photometrical oximeters
    • A61B5/1459—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using optical sensors, e.g. spectral photometrical oximeters invasive, e.g. introduced into the body by a catheter
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/42—Detecting, measuring or recording for evaluating the gastrointestinal, the endocrine or the exocrine systems

Definitions

  • the invention relates to a method for detecting a particular bacterium in a hollow organ of the human or animal gastrointestinal tract, an endocapsule for detecting such a bacterium and their use.
  • a common cause of complaints of the upper gastrointestinal tract is a bacterial infestation of its organs.
  • Helicobacter pylori infestation is believed to be responsible for a whole range of gastric disorders associated with increased gastric acid secretion. These include, for example, the Type B
  • Gastritis in about 75% of gastric ulcers and almost all twelve-finger gut ulcers.
  • the examination of the hollow organs of the gastrointestinal tract for colonization with bacteria, in particular colonization with Helicobacter pylori is therefore an important part of the diagnosis of gastric diseases.
  • Helicobacter pylori is detected via a breath test in which C-13 labeled urinary tract is administered to a patient.
  • the C-13 labeled CO2 produced by the decomposition of urea into ammonia and CO2 is detected in the exhaled air.
  • Other methods of detecting Helicobacter pylori are indicative of typical blood levels, such as pepsinogen or gastrin. However, such methods are expensive and not very reliable.
  • stomach for colonization with Helicobacter pylori Another way to examine the stomach for colonization with Helicobacter pylori is the so-called gastroscopy ("gastroscopy").
  • gastroscopy the gastroenterologist takes a biopsy from the gastric mucosa to examine at a later time for an infection with Helicobacter pylori.
  • a well-known examination procedure for the tissue sample is for example, the Helicobacter urease test (HU test, HUT short).
  • the biopsy is placed in a test medium (measuring solution), which consists of a nutrient solution for this bacterium, urea and an indicator (litmus).
  • the bacterium splits the urea (CO (NH 2 ) 2) by urease into ammonia (NH 3 ) and carbon dioxide (CO2). • The ammonia then colors the indicator red. The test result can be seen after a few minutes. The onset of color change from yellow to red is not clearly identifiable under unfavorable conditions.
  • a gastroscopy has a low patient acceptance and is in particular unsuitable for carrying out so-called screening examinations.
  • an endoscopy capsule which is also referred to as capsule endoscope or capsule endoscope and known for example from DE 101 42 253 C1 and from the corresponding US 2003/0060702 Al is.
  • an endocapsule is a swallowable capsule which is in wireless communication with a transfer station outside the patient's body.
  • the endocapsule may also be navigable in a magnetic gradient field.
  • Such a capsule may be equipped with sensors that allow it to measure or detect, for example, temperature, electrical conductivity, pH or chemical substances inside a hollow organ.
  • Such an endocapsule may also be suitable for targeted drug administration.
  • the object of the present invention is to provide an endocapsule, its use and a method with such an endocapsule for detecting a particular bacterium in a hollow organ of the human or animal gastrointestinal tract.
  • the object according to the invention is achieved by a method having the features according to claim 1.
  • the bacterium is detected by means of at least one of its metabolic products with the aid of an endocapsule containing a sensor for the metabolite containing tissue introduced into the hollow organ.
  • a bacterium can be identified very reliably by its metabolites.
  • the metabolites are detected directly at the site of their formation, ie in situ. Although such an endocapsule is usually swallowed, it behaves completely inert in the body. For this reason, the method according to the invention has a high level of patient acceptance.
  • the ingestion of an endocapsule is particularly patient-friendly, in comparison with the detection methods known from the prior art, such as, for example, endoscopic examinations including biopsy.
  • the detection takes place of bacteria with high accuracy and measurement certainty.
  • the method according to the invention uses the endocapsule as the only working medium, so that no additional aids, for example additional laboratory or analytical apparatus, are necessary for detecting the particular bacterium.
  • the hollow organ is supplied with a starting material which can be absorbed by the particular bacterium.
  • the hollow organ is supplied with a starting substance which is chosen such that it can be metabolized by the bacterium whose detection is desired. At least one metabolite of the bacterium, which originated from the starting substance, is now detected.
  • the targeted administration of a starting substance increases the production of the bacterium with regard to the metabolic product whose detection is sought.
  • the concentration of the metabolite in the hollow organ increases, the detection is easier and more accurate due to the increased level.
  • starting substance From the combination of starting substance, end product and bacterium can be concluded in all probability on the presence of a particular bacterium. If, for example, the detection of a particular bacterium is desired, it can be supplied to the hollow organ by offering a suitable starting substance, which is known to be metabolized by the bacterium. In this case, an elevated level of the associated metabolite should be detectable. In the case of negative evidence, a starting substance can be supplied to the hollow organ, which is known to be metabolized by the bacterium. If, nevertheless, a metabolic product, which can be assigned to this starting substance, can be detected, this could indicate an error in direct detection.
  • the starting substance can be administered, for example, in the form of a tablet or capsule which disintegrates in the hollow organ, for example the stomach. In any case, by the targeted gift of a Starting substance, the detection reliability of the process can be increased.
  • the concentration of the metabolite is measured at least once before introducing the starting substance into the hollow organ and at least once after introduction of the starting substance into the hollow organ.
  • a procedure allows a relative measurement, which in the simplest case is determined by the difference between the values before and after introduction of the starting substance.
  • Relative measurement allows the detection of a specific bacterium using a metabolic product, which occurs even in the absence of the bacterium in the hollow organ. For example, first the starting concentration of a certain metabolite in the hollow organ is measured, after administration of the starting substance and waiting for an optionally required duration of action, a value of the metabolite markedly higher than the starting concentration is a very strong indication of the presence of the particular bacterium.
  • the measurements of the concentration of the metabolite are related to the time at which the starting substance is introduced into the hollow organ.
  • this time By taking this time into account when measuring the concentration of the metabolite, it is possible to take into account specific time constants for the bacterium whose detection is sought. For example, it is possible that a bacterium has only produced a sufficient amount of the metabolite after a certain time. A measurement which would be carried out too early after the introduction of the starting substance into the hollow organ would therefore be of little significance, since the concentration of the metabolite, based on the basic value, would have increased only slightly.
  • the temporal correlation of the concentration measurement with the time of administration of the starting substance allows such a time behavior of the bacterial consideration. The evidence can be increased.
  • the time profile of the concentration of at least one metabolic product is determined on the basis of a multiplicity of chronologically successive measurements.
  • a time-dependent concentration curve of the metabolite makes it possible to study the temporal behavior of the productivity of the bacterium in relation to the considered metabolite. Such a time-dependent curve allows a differentiated assessment of the reaction of the specific bacterium on the administered starting substance.
  • the particular bacterium is Helicobacter pylori, which is administered urea as the starting substance by introduction into the hollow organ. As metabolite carbon dioxide (CO2) is detected. Helicobacter pylori is responsible for a large number of different clinical pictures of the hollow organs of the gastrointestinal tract. Helicobacter pylori decomposes urea (CO (NH 2 ) 2) into bicarbonate (HCO 3 " ) and ammonia (NH 3 ) . The hydrogen carbonate decomposes in the aqueous environment of the plant
  • the liquid present in the hollow organ for example the gastric juice, accumulates with CO 2 .
  • the increased CO 2 content of the gastric juice can be determined by means of a difference measurement before and after urea administration.
  • Helicobacter pylori is detected by an increased CO 2 concentration of the gastric juice.
  • Helicobacter pyroli which urea (CO (NH 2 ) 2 ) from the starting material by
  • Helicobacter pylori produces ammonia to protect itself from the acidic environment of the Gastrointestinal tract, especially the high hydrochloric acid concentration in the stomach to protect. Locally present ammonia leads to a neutralization of the gastric mucosa in the area of colonization with Helicobacter pylori. Since ammonia under normal circumstances in a hollow organ of the gastrointestinal tract, such as the stomach, does not occur or only in very low concentrations, its detection is sufficient as a very strong indication of the presence of Helicobacter pylori.
  • a combination of the ammonia measurement for example with a measurement of the CO 2 content, serves to increase the detection reliability, but is not absolutely necessary.
  • the starting substance is introduced from the endocapsule into the hollow organ.
  • the starting substance can be offered directly to the bacterium which may be present in the hollow organ.
  • a corresponding reaction of the bacterium can be measured on the basis of the more or less immediately increasing level of the reaction products.
  • the starting substance is introduced into a conspicuous partial region of the hollow organ.
  • This conspicuous partial area has previously been identified by means of an optical examination, for example with the aid of a camera located on board the endoscope.
  • the identification of conspicuous areas can be done except by purely optical examination using dyes such as Kogorot or Methylene Blue.
  • dyes such as Kogorot or Methylene Blue.
  • those regions of the hollow organ which are colonized by the specific bacterium, in particular Helicobacter pylori can be stained.
  • Device-related object of the invention is achieved by an endocapsule having the features of claim 11.
  • the endocapsule according to the invention which can be introduced into a hollow organ of the human or animal gastrointestinal tract, has a sensor which is designed such that it responds to a metabolic product of a particular bacterium.
  • the senor of the endocapsule comprises a sensor field communicating with its surroundings with a sensor layer which undergoes a measurable change in property upon contact with the bacterium or one of its metabolic products.
  • the endocapsule can advantageously be provided with the appropriate sensor layer, which in each case reacts sensitively to those bacteria or metabolites whose detection is desired.
  • the senor comprises a resistance measuring device for measuring the ohmic resistance of the sensor layer or a Densiometeran Aunt for measuring the optical density of the sensor layer.
  • the measurement of the ohmic resistance or the optical density are technically easy to control and therefore easy and precise feasible.
  • a wide range of property changes of the sensor layer is recorded based on these two physical parameters.
  • the sensor layer comprises silver chloride.
  • Silver chloride dissolves in ammonia, but is over gastric acid resistant. Ammonia is a strong indication of the presence of Helicobacter pylori. For this reason, a silver chloride layer as a sensor layer is well suited for the detection of Helicobacter pylori.
  • the senor comprises a measuring chamber which is closed off from the environment of the endocapsule by a membrane which is preferably permeable to the metabolic product.
  • a membrane with such properties is commonly referred to as semipermeable.
  • the senor of the endocapsule comprises a voltage measuring device with the aid of which the potential difference between the outer space of the endocapsule and the interior of the measuring chamber can be measured.
  • the senor comprises a pH meter for measuring the pH in the measuring chamber.
  • Potential difference measurements and pH measurements are technically easy to control and allow easy and reliable detection of the metabolite.
  • the senor of the endocapsule comprises a membrane permeable to ammonia.
  • the presence of ammonia is a strong indication of colonization with Helicobacter pylori.
  • Such an endocapsule is therefore particularly suitable for the detection of this bacterium.
  • the senor of the endocapsule comprises a carbon dioxide sensor.
  • An increased carbon dioxide Oxide concentration in a hollow organ of the gastrointestinal tract is also a strong indication of the presence of Helicobacter pylori.
  • the endocapsule has a suitable for receiving a starting substance reservoir.
  • the starting substance can be introduced directly into the hollow organ.
  • the time of administration is thus known very precisely, the starting substance can quickly take effect.
  • the reaction of the bacterium can be observed on the administration of the starting material.
  • the reservoir is closed to the exterior of the endocapsule by a gastric juice-soluble layer.
  • the reservoir can be closed particularly easily in the manner indicated.
  • the endocapsule has a controllable delivery device with which the starting substance can be released from the reservoir or released to the environment of the endocapsule.
  • a dispenser may, for example, be a valve.
  • an endocapsule according to any one of claims 11 to 23 is used for the detection of a metabolic product of a particular bacterium in a hollow organ of the human or animal gastrointestinal tract.
  • FIG. 1 shows a first embodiment of an endocapsule according to the invention in a longitudinal section
  • An endocapsule 2 shown in FIG. 1 has a housing substantially ellipsoidal in shape to the main axis H.
  • Colinear to the main axis H is located inside the endocapsule 2, a bar magnet 3, which allows the magnetic forces caused by navigation of the endocapsule 2 in a magnetic gradient field.
  • a lens 4 is embedded in the housing.
  • a CCD sensor 5 for receiving image data is arranged on the inside of the lens 4.
  • the acquired image data are transmitted by means of a transmission unit 6, which has both the function of a transmitter and the function of a receiver, to a remote from the Endokapsel 2 transmission station.
  • the transmission unit 6 is connected to an antenna 7.
  • the transmission station will be discussed in more detail later (FIG. 4).
  • the endocapsule 2 shown in FIG. 1 serves for the detection of Helicobacter pylori in the human stomach.
  • This bacterium produces ammonia as a typical metabolite.
  • the colonization of the stomach with Helicobacter pylori can therefore be detected by the ammonia content of the gastric juice or the ammonia content in the mucus of the gastric inner wall (gastric mucosa) is measured.
  • the endocapsule 2 has a sensor 10 which comprises a measuring chamber 11 arranged in the interior of the endocapsule 2. This is completed with a preferably permeable to ammonia membrane 12 with respect to the outer space of the endocapsule 2. Consequently, ammonia can accumulate in the interior of the measuring chamber 11 when the outside of the membrane 12 is in contact with an ammonia-containing liquid.
  • Detection of the ammonia in the measuring chamber 11 is carried out optionally by measuring the potential difference between the outer space of the endocapsule 2 and the interior of the measuring chamber 11 or by measuring the pH in the interior of the measuring chamber 11.
  • the endocapsule 2 has a suitable measuring device 13 for performing such measurements on. This is, if necessary, a voltage meter (potentiometer) or a pH meter.
  • the measuring device 13 is connected to electrodes 14 which are arranged in the interior of the measuring chamber 11 or on the outside of the endocapsule 2 and allow corresponding measurements.
  • the measurement data obtained with the aid of the measuring device 13 are sent via a data line 8 to the transmission unit 6. With the help of the transmission unit 6, the measurement data is transmitted to a remote from the Endokapsel 2 transfer station.
  • the endocapsule 2 also has a reservoir 15 located in its interior, which serves to take up urea as the starting substance for Helicobacter pylori. With the aid of a dispensing unit 16, the reservoir 15 can be opened, so that the urea present in it is discharged to the environment of the endocapsule 2.
  • a dispensing device is a control unit, which is connected via the data line 8 to the transmission unit 6. The control unit can be controlled remotely from the transfer station, so that the urea discharges of the endocapsule 2 are influenced in a targeted manner can.
  • the reservoir 15 is closed with a bimetal 17, which is acted upon to open the reservoir 15 by means of the dispensing unit 16 with power.
  • the endocapsule 2 shown in FIG. 1 may optionally comprise a CO 2 sensor (not shown in greater detail ) (for example a Severinghaus electrode). With this it is possible to measure the CO 2 concentration of the gastric juice.
  • a CO 2 sensor for example a Severinghaus electrode.
  • FIG. 2 shows a second exemplary embodiment of an endocapsule 2.
  • this has a sensor layer 18 of silver chloride arranged in a sensor field.
  • the silver chloride layer 18 which is otherwise insoluble in the acid gastric juice, begins to dissolve.
  • the reduced cross-section of the sensor layer 18 as a result of the dissolution process leads to a change in its ohmic resistance, which is measured with the measuring device 13.
  • the measured values are transmitted via the data line 8 to the transmission unit 6 and from there to the transmission station remote from the endocapsule 2.
  • FIG. 3 shows a third exemplary embodiment of an endo capsule 2.
  • This has a densiometer arrangement as the sensor 10, by means of which the optical properties of the sensor layer 18 are measured.
  • the likewise consisting of silver chloride sensor layer 18 is located in a accessible from the outside of the endocapsule 2 ago measuring space. Their optical transmission / density is measured by illuminating them by a lamp 20 and measuring the optical transmission with the aid of a photocell 21.
  • This measurement is carried out with the measuring device 13, which transmits the measured data via the Data line 8 sends to the transmission unit 6 for transmission to the remote transmission station.
  • the reservoir 15, which is likewise arranged in the interior of the endocapsule 2, is closed with a flap 22 with respect to the outer space of the endocapsule 2.
  • the flap 22 can be opened remotely by means of the dispensing unit 16.
  • a patient 25 is in a magnet coil system 26 suitable for magnetic capsule endoscopy.
  • the endocapsule 2 is magnetically navigable by means of the magnetic coil system 26.
  • the data sent by the transmission unit 6 of the endocapsule 2 are received by means of antennas 27 and forwarded to the transmission station 28.
  • the information obtained from the endocapsule 2 for example image information, concentration values of ammonia (NH 3 ) or carbon dioxide (CO 2), etc., are visualized on the monitor 29.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Surgery (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Pathology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Biophysics (AREA)
  • Optics & Photonics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Computer Networks & Wireless Communication (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Endocrinology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physiology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Endoscopes (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Capsule endoscopique (2), utilisation de cette capsule endoscopique (2) et procédé servant à indiquer la présence d'une bactérie déterminée dans un organe creux des voies gastro-intestinales de l'homme ou de l'animal et consistant à détecter cette bactérie au moyen d'au moins un de ses produits métaboliques à l'aide d'une capsule endoscopique (2) introduite dans l'organe creux et contenant un capteur (10) du produit métabolique.
EP09732765A 2008-04-18 2009-04-02 Capsule endoscopique Withdrawn EP2265168A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102008019643 2008-04-18
PCT/EP2009/053937 WO2009127528A1 (fr) 2008-04-18 2009-04-02 Capsule endoscopique

Publications (1)

Publication Number Publication Date
EP2265168A1 true EP2265168A1 (fr) 2010-12-29

Family

ID=40749863

Family Applications (1)

Application Number Title Priority Date Filing Date
EP09732765A Withdrawn EP2265168A1 (fr) 2008-04-18 2009-04-02 Capsule endoscopique

Country Status (8)

Country Link
US (1) US8870767B2 (fr)
EP (1) EP2265168A1 (fr)
JP (1) JP5595378B2 (fr)
KR (1) KR101608550B1 (fr)
CN (2) CN102006822B (fr)
BR (1) BRPI0911101A2 (fr)
MX (1) MX2010011441A (fr)
WO (1) WO2009127528A1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2659834A1 (fr) 2012-04-30 2013-11-06 Siemens Aktiengesellschaft Capsule Hp à optimisation des coûts

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2011008684A (es) 2009-02-17 2011-09-06 Siemens Ag Capsula endoscopica.
CN102316787A (zh) * 2009-02-17 2012-01-11 西门子公司 胃镜
EP2398376A1 (fr) * 2009-02-17 2011-12-28 Siemens Aktiengesellschaft Gastroscope
DE102010010763A1 (de) 2010-03-09 2011-09-15 Siemens Aktiengesellschaft Verfahren zur Eradikation von Helicobacter pylori
DE102010020614A1 (de) * 2010-05-14 2011-11-17 Friedrich-Alexander-Universität Erlangen-Nürnberg Endoskopiekapsel zum Nachweis eines Stoffwechselproduktes eines in oder an der Wand eines Hohlorgans des menschlichen oder tierischen Gastrointestinaltraktes befindlichen Erregers
US8771201B2 (en) * 2010-06-02 2014-07-08 Vital Herd, Inc. Health monitoring bolus
GB2489193A (en) * 2010-10-29 2012-09-26 Univ Warwick Ingestible sensor device to detect gases and VOCs in the gastrointestinal tract
JP2014525738A (ja) * 2011-07-01 2014-10-02 コモンウェルス サイエンティフィック アンド インダストリアル リサーチ オーガニゼイション 哺乳動物の胃の中のガスを測定するためのシステム、方法、及び装置
JP6137450B2 (ja) * 2013-01-10 2017-05-31 国立大学法人 筑波大学 大腸癌検出用内視鏡
DE102013202257A1 (de) 2013-02-12 2013-08-22 Siemens Aktiengesellschaft Endoskopiekapsel und Verfahren zur Herstellung einer Endoskopiekapsel
GB201304738D0 (en) 2013-03-15 2013-05-01 Mars Inc Sampling Device
US20140316222A1 (en) * 2013-04-23 2014-10-23 Given Imaging Ltd. In-vivo device, system and method for detection of helicobacter pylori
DE102013227086A1 (de) 2013-12-23 2015-06-25 Siemens Aktiengesellschaft Biopsiezange
WO2015180754A1 (fr) 2014-05-26 2015-12-03 Siemens Aktiengesellschaft Électrode de mesure destinée à un détecteur pour l'analyse d'un milieu de mesure quant à la présence de helicobacter pylori
WO2015180753A1 (fr) * 2014-05-26 2015-12-03 Siemens Aktiengesellschaft Dispositif et procédé pour l'analyse d'un milieu de mesure quant à la présence de helicobacter pylori
WO2015180748A1 (fr) 2014-05-26 2015-12-03 Siemens Aktiengesellschaft Dispositif de mesure pour détecter de l'ammoniaque dans les sucs gastriques
WO2015180747A1 (fr) 2014-05-26 2015-12-03 Siemens Aktiengesellschaft Dispositif de mesure pour détecter de l'ammoniaque dans les sucs gastriques
WO2015197135A1 (fr) * 2014-06-27 2015-12-30 Siemens Aktiengesellschaft Détecteur d'helicobacter pylori fondé sur une résistance électrique
WO2016000756A1 (fr) 2014-07-01 2016-01-07 Siemens Aktiengesellschaft Dispositif de mesure pour la détection d'ammoniac dans le suc gastrique
EP3193729B1 (fr) 2014-09-17 2020-07-01 Mars, Incorporated Dispositif d'échantillonnage
CA2961307C (fr) 2014-09-17 2023-01-10 Mars Incorporated Dispositif
WO2016045700A1 (fr) * 2014-09-23 2016-03-31 Siemens Aktiengesellschaft Capteur d'helicobacter pylori utilisant une détection optique
US9750923B2 (en) * 2014-11-19 2017-09-05 Velóce Corporation Wireless communications system integrating electronics into orally ingestible products for controlled release of active ingredients
CN105030183B (zh) * 2015-09-09 2016-11-16 京东方科技集团股份有限公司 一种内窥镜及医疗检测系统
CN106137099A (zh) * 2016-09-27 2016-11-23 重庆大学 基于云端服务的智能胶囊检测系统
US20180206726A1 (en) * 2016-12-07 2018-07-26 Progenity Inc. Gastrointestinal tract detection methods, devices and systems
KR102080785B1 (ko) * 2018-05-11 2020-02-24 김성준 장내 미생물 표적 채취용 캡슐
CN109662693A (zh) * 2018-12-29 2019-04-23 深圳普门科技股份有限公司 一种基于气体检测的Hp微型检测胶囊
KR20220153058A (ko) * 2020-03-10 2022-11-17 안콘 메디컬 테크놀로지스 (상하이) 컴퍼니 리미티드 의료용 검사 장치 및 의료용 검사 장치의 측정 부재
KR102379748B1 (ko) * 2020-07-13 2022-03-29 재단법인대구경북과학기술원 헬리코박터 파일로리 진단캡슐
CN113081075B (zh) * 2021-03-09 2022-03-04 武汉大学 一种具有主动式活检与施药功能的磁控胶囊

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5292344A (en) * 1992-07-10 1994-03-08 Douglas Donald D Percutaneously placed electrical gastrointestinal pacemaker stimulatory system, sensing system, and pH monitoring system, with optional delivery port
US5477854A (en) 1993-09-16 1995-12-26 Synectics Medical, Inc. System and method to monitor gastrointestinal Helicobacter pylori infection
US5507289A (en) 1993-09-16 1996-04-16 Synectics Medical, Inc. System and method to diagnose bacterial growth
JPH07323034A (ja) * 1994-05-31 1995-12-12 Hitachi Ltd 細菌検出装置
US5989840A (en) 1997-05-29 1999-11-23 Americare International Diagnostics, Inc. Estimation of active infection by heliobacter pylori
AU7722398A (en) * 1997-05-29 1998-12-30 Joseph P. D'angelo Estimation of active infection by helicobacter pylori
US6509169B2 (en) 2000-07-14 2003-01-21 University Of West England, Bristol Detection of Helicobacter pylori
DE10142253C1 (de) 2001-08-29 2003-04-24 Siemens Ag Endoroboter
US20040077093A1 (en) * 2002-07-12 2004-04-22 Baxter International Inc. Method and apparatus for the detection of the presence of a bacteria in the gastrointestinal tract of a subject
WO2004039233A2 (fr) * 2002-10-31 2004-05-13 Given Imaging Ltd. Systeme et methode de detection in vivo de h. pylori
JP4012097B2 (ja) * 2003-03-06 2007-11-21 オリンパス株式会社 カプセル型医療装置回収装置
US8021356B2 (en) 2003-09-29 2011-09-20 Olympus Corporation Capsule medication administration system, medication administration method using capsule medication administration system, control method for capsule medication administration system
JP4520161B2 (ja) 2004-01-08 2010-08-04 オリンパス株式会社 カプセル型医療装置
US8306592B2 (en) * 2003-12-19 2012-11-06 Olympus Corporation Capsule medical device
JP2005185567A (ja) 2003-12-25 2005-07-14 Olympus Corp 医療用カプセル装置
DE602005023608D1 (de) * 2004-05-21 2010-10-28 Given Imaging Ltd Vorrichtung, system und verfahren zur in-vivo-probenentnahme
WO2006045011A2 (fr) 2004-10-20 2006-04-27 The Board Of Trustees Of The Leland Stanford Junior University Endocapsule
EP1827388A2 (fr) * 2004-12-14 2007-09-05 E-Pill Pharma Ltd. Administration locale de medicaments ou de substances mettant en jeu une augmentation de la permeabilite d'origine electronique
CN1868396A (zh) * 2005-05-27 2006-11-29 上海飞恩微电子有限公司 一种可释药的胶囊内窥镜
DE102005032378A1 (de) 2005-07-08 2007-01-11 Siemens Ag Magnetische navigierbare Endoskopie-Kapsel mit Sensor zur Erfassung einer physiologischen Größe
DE102005032290A1 (de) * 2005-07-11 2007-01-18 Siemens Ag Endoskopiekapsel sowie Verfahren zur Diagnose und/oder Therapie mittles einer Endoskopiekapsel
KR20080077182A (ko) * 2005-12-16 2008-08-21 올림푸스 가부시키가이샤 피검체 내 위치 검출 시스템
WO2008154416A2 (fr) * 2007-06-07 2008-12-18 Microchips, Inc. Biocapteurs et réseaux électrochimiques

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO2009127528A1 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2659834A1 (fr) 2012-04-30 2013-11-06 Siemens Aktiengesellschaft Capsule Hp à optimisation des coûts

Also Published As

Publication number Publication date
US20110092787A1 (en) 2011-04-21
JP2011516226A (ja) 2011-05-26
BRPI0911101A2 (pt) 2015-10-06
CN102006822B (zh) 2015-01-21
CN104473619A (zh) 2015-04-01
WO2009127528A1 (fr) 2009-10-22
KR101608550B1 (ko) 2016-04-01
JP5595378B2 (ja) 2014-09-24
MX2010011441A (es) 2010-11-09
US8870767B2 (en) 2014-10-28
KR20100134043A (ko) 2010-12-22
CN102006822A (zh) 2011-04-06

Similar Documents

Publication Publication Date Title
EP2265168A1 (fr) Capsule endoscopique
DE60225669T2 (de) System zur bestimmung der in-vivo-zustände in körperlumina
DE69839012T2 (de) Gerät zur bestimmung von störungen der perfusion bei einem patienten
EP2398374A1 (fr) Capsule endoscopique
WO2010094651A1 (fr) Gastroscope
EP2398376A1 (fr) Gastroscope
DE102005032378A1 (de) Magnetische navigierbare Endoskopie-Kapsel mit Sensor zur Erfassung einer physiologischen Größe
EP3389489A1 (fr) Dispositif de mesure de la motilité de l'estomac et de la pression dans l'estomac d'un animal d'élevage
WO2010094649A1 (fr) Appareil diagnostique
WO2010108759A1 (fr) Détecteur d'helicobacter pylori
DE102005032290A1 (de) Endoskopiekapsel sowie Verfahren zur Diagnose und/oder Therapie mittles einer Endoskopiekapsel
DE102013221591A1 (de) Tierüberwachungssystem
DE19801573A1 (de) Sammler für lokale Probeflüssigkeiten und Verwendung eines solchen Sammlers im menschlichen oder tierischen Verdauugssystem
DE102008035542A1 (de) Verfahren zur Ermittlung von Messdaten aus dem Magen eines Patienten
DE102010006969A1 (de) Gastroskop
DE102009023056A1 (de) Gastroskop
DE102009023037A1 (de) Gastroskop
WO2014029570A1 (fr) Instrument capteur
DE102009023035A1 (de) Diagnosegerät
DE102004016694B4 (de) Verfahren zur Gewinnung medizinisch relevanter Daten aus dem Gastrointestinaltrakt eines Menschen oder eines Tieres sowie eine dafür geeignete Darreichungsform
DE102010034470B4 (de) Vorrichtung, System und Verfahren zum Untersuchen eines Körperlumens
WO2015180753A1 (fr) Dispositif et procédé pour l'analyse d'un milieu de mesure quant à la présence de helicobacter pylori
DE102010006973A1 (de) Gastroskop
WO2016000756A1 (fr) Dispositif de mesure pour la détection d'ammoniac dans le suc gastrique
DE102009009290A1 (de) Gastroskop

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20101018

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL BA RS

DAX Request for extension of the european patent (deleted)
RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: SIEMENS AKTIENGESELLSCHAFT

17Q First examination report despatched

Effective date: 20161202

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: SIEMENS AKTIENGESELLSCHAFT

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20170413